Page 876 - Cote clinical veterinary advisor dogs and cats 4th
P. 876

424   Hemangiosarcoma


            PROGNOSIS & OUTCOME               •  Metronomic chemotherapy using cyclophos-  Technician Tips
                                                phamide and piroxicam has been shown to   All masses in dogs and cats, even slow growing
  VetBooks.ir  pericytomas with appropriate treatment. This   days after incomplete tumor excision of   tumors.
                                                                                 ones, should be aspirated to rule out malignant
                                                result in tumor control for more than 400
           Prognosis is excellent for most hemangio-
                                                soft-tissue sarcomas. Marginal tumor exci-
           includes complete surgical resection with clean
                                                                                 Client Education
           histopathologic margins or incomplete resection
           combined with radiation therapy.     sion with intralesional chemotherapy beads   Pet owners can be educated to monitor their
                                                can provide long-term control and may be
           •  Combined surgery with radiation therapy   considered as an alternative to radiation   pets for the occurrence of masses under the
            results in long-term tumor control in 86%   therapy for some cases.  skin and have the masses evaluated in a timely
            of dogs with hemangiopericytoma. Median   •  High-grade hemangiopericytoma is rare, and   fashion. Early detection may allow easier treat-
            survival times for dogs treated this way are   information is limited regarding prognosis.  ment by surgery and may help avoid the need
            > 5 years, with 85% tumor free at 3 years.                           for radiation therapy.
           •  Radiation  therapy  alone  has  resulted  in    PEARLS & CONSIDERATIONS
            1-year tumor control rates of up to 75% at                           SUGGESTED READING
            higher doses. However, these studies used   Comments                 Liptak JM, et al: Soft tissue sarcomas. In Withrow
            suboptimal radiation dose schedules. In   Despite uncertainty about the cell of origin for   SJ, et al, editors: Small animal clinical oncology,
            certain situations in which surgery is not   these tumors, hemangiopericytoma, peripheral   Philadelphia, 2013, Saunders, pp 356-380.
            indicated,  radiation therapy  may be used   nerve sheath tumor, schwannoma, and neurofi-  AUTHOR: John Farrelly, DVM, MS, DACVIM, DACVR
            for providing some degree of tumor control.  brosarcoma generally show the same biological   EDITOR: Kenneth M. Rassnick, DVM, DACVIM
           •  Palliative radiation therapy after incomplete   behavior and should be treated in the same way.
            tumor excision resulted in tumor control in
            65% of dogs with soft-tissue sarcomas at 5
            years in one study.








                                                                                          Video
            Hemangiosarcoma                                                             Available     Client Education
                                                                                                         Sheet

            BASIC INFORMATION                 RISK FACTORS                       Clinical Presentation
                                              Dogs:
           Definition                         •  Cutaneous:  dermal  hemangiosarcoma   DISEASE FORMS/SUBTYPES
           A  malignant,  highly  metastatic  tumor   (HSA) arises on nonhaired skin and   Dogs:
           arising from vascular endothelial cells. Most   is associated with ultraviolet (UV) light     •  Cutaneous
           commonly  arises  in  the  spleen,  right  auricle   exposure.          ○   Tends to arise on lightly haired areas
           or right atrium, and skin or subcutaneous     •  Subcutaneous HSA arises in haired skin and   (e.g., ventral abdomen). Tumors < 5 cm
           tissues.                             is not associated with UV exposure.  in diameter and confined to the dermis
                                                                                     are classified as stage I. Tumors that are >
           Synonyms                           ASSOCIATED DISORDERS                   5 cm in diameter or invade subcutaneous
           Angiosarcoma, HSA, malignant hemangioen-  Dogs:                           or deeper tissues are classified as stage II.
           dothelioma                         •  Cutaneous                       •  Noncutaneous
                                                ○   UV exposure may predispose to cuta-  ○   Splenic lesions are most common, followed
           Epidemiology                           neous  hemangioma  or  squamous  cell    by right atrial/auricular appendage. Primary
           SPECIES, AGE, SEX                      carcinoma.                         HSA of the liver can occur, but most often,
           •  Dogs: common                    •  Noncutaneous                        hepatic lesions are metastases from another
            ○   Cutaneous: adults, no sex predisposition  ○   With splenic, hepatic, or right atrial/  site. HSA can arise anywhere.
            ○   Noncutaneous: adults (median, 8 years),   auricular appendage HSA, potentially   ○   Cardiac tamponade due to intrapericardial
              neutered animals may be at increased     life-threatening hemorrhage can occur.   hemorrhage from the tumor site
              risk                                Occasionally, cutaneous or subcutane-  ○   Occasionally can be an incidental finding
           •  Cats:  adults  (median,  8  years),  males  >   ous HSA lesions may be associated with   on physical exam (splenomegaly), abdomi-
            females; uncommon                     significant bleeding.              nal ultrasound, or echocardiography
                                                ○   Cardiac HSA is the most common reason   Cats:
           GENETICS, BREED PREDISPOSITION         for pericardial effusion. Pericardial effu-  •  Subcutaneous and splenic lesions are most
           •  Dogs                                sion can result in potentially fatal cardiac   common, but HSA can arise anywhere in
            ○   Cutaneous: no genetics known, although   tamponade.                the body, including ocular structures, bone,
              short-haired breeds are predisposed (e.g.,   ○   Splenic, hepatic, and right atrial/auricular   gastrointestinal (GI) tract, and skin.
              whippets, pit bulls, Dalmatians)    appendage HSA are associated with cardiac
            ○   Noncutaneous: genetic predisposition   arrhythmias.              HISTORY, CHIEF COMPLAINT
              strongly suspected with evidence in golden   ○   In any patient with HSA, disseminated   Dogs:
              retrievers (estimated 1 in 5 lifetime risk);   intravascular coagulation (DIC) may arise   •  Cutaneous
              German shepherds and other large breeds   because formation of abnormal (tumor-  ○   History of extensive sunlight exposure;
              are overrepresented.                related)  vascular  channels  triggers  the   development of one or more cutaneous
           •  Cats: specific breed predisposition known  coagulation cascade.        masses

                                                     www.ExpertConsult.com
   871   872   873   874   875   876   877   878   879   880   881